Mean HbA1c and HbA1c variability are associated with differing diabetes-related complications in patients with type 2 diabetes mellitus. (October 2022)

• Record Type: Journal Article
• Authors: Wu, Tzu-En; Su, Yu-Wen; Chen, Harn-Shen
• Is Part Of: Diabetes research and clinical practice. Volume 192(2022)
• Publication Date: 2022-10
• Subjects: HbA1c variability -- Mean HbA1c -- Diabetes complications; Diabetes -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462
• DOI: 10.1016/j.diabres.2022.110069
• Languages: English
• ISSNs: 0168-8227

Abstract

Highlights: What is known before our study: Cumulative evidence shows that long-term glycemic control is the main risk factor for the development of micro- and macro-vascular complications in diabetic patients. Several studies also revealed that HbA1c variability was positively associated with micro- and macro-vascular complications, as well as mortality. What new information do we bring: Our study revealed that both HbA1c-mean and HbA1c-SD predicted most of the complications of diabetes. However, HbA1c-mean was more effective at predicting retinopathy, while HbA1c-SD was more effective at predicting deterioration of renal function and increased mortality. Abstract: Aims: To study the different effects of mean HbA1c and HbA1c variability on diabetes-related complications in patients with type 2 diabetes mellitus. Methods: 1869 patients with type 2 diabetes were followed-up for a median of 9.5 years in a Diabetes Shared Care Program. Mean HbA1c (HbA1c-mean) and standard deviation of HbA1c (HbA1c-SD) were calculated during the first 5 years. The clinical outcomes included nephropathy (urine albumin-to-creatinine ratio [UACR] > 300 mg/g and doubling of serum creatinine), retinopathy (any and advanced), and mortality (due to all-causes, and cardiovascular disease [CVD]). Results: HbA1c-mean was independently associated with UACR > 300 mg/g (Hazard ratio [HR] 1.308 [95% confidence interval {CI}, 1.194–1.433]), any retinopathy (HR 1.274 [1.171–1.385]), and advanced retinopathy (HR 1.237 [1.014–1.509]). HbA1c-SD was independently associated with UACR > 300 mg/g (HR 1.478 [1.189–1.837]), doubling of serum creatinine (HR 2.133 [1.470–3.095]), all-cause mortality (HR 1.880 [1.561–2.266]), and CVD mortality (HR 1.431 [1.069–1.915]). Receiver operating characteristic (ROC) curves showed HbA1c-mean was more associated with any retinopathy, whereas HbA1c-SD was more associated with doubling of serum creatinine, all-cause and CVD mortality. Conclusion: Both HbA1c-mean and HbA1c-SD predicted most diabetes-related complications in patients with type 2 diabetes. However, HbA1c-mean was more effective at predicting retinopathy, while HbA1c-SD was more effective at predicting deterioration of renal function and increased mortality.